Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases.
J Med Chem
; 61(16): 6964-6982, 2018 08 23.
Article
in En
| MEDLINE
| ID: mdl-29712435
Full text:
1
Database:
MEDLINE
Main subject:
Inflammatory Bowel Diseases
/
Renal Insufficiency, Chronic
/
Prolyl-Hydroxylase Inhibitors
/
Genetic Diseases, Inborn
/
Anemia
/
Neoplasms
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
Year:
2018
Type:
Article